RHÖN-KLINIKUM AG

  • WKN: 704230
  • ISIN: DE0007042301
  • Land: Deutschland

Nachricht vom 09.07.2012 | 15:58

RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


RHÖN-KLINIKUM AG 

09.07.2012 15:58

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Notification according to section 26 para. 1 WpHG 

Credit Suisse Group AG, Zürich, Switzerland, and Credit Suisse AG, Zürich,
Switzerland, notified us pursuant to section 25 para. 1 WpHG of the
following:

1) On 2 July 2012, Credit Suisse Group AG exceeded the threshold of 5% of
the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad
Neustadt a. d. Saale, Germany. On that date, Credit Suisse Group AG held
5.81% of the voting rights in RHÖN-KLINIKUM AG (equals 8,025,638 voting
rights). From these voting rights a proportion of 3.83% (equals 5,294,944
voting rights) is based on voting rights pursuant to sections 21, 22 WpHG
and a proportion of 1.98% (equals 2,730,694 voting rights) is based on
(financial / other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 1.98% (equals 2,730,694 voting rights) is held indirectly (chain of
controlled undertakings: Credit Suisse AG, Credit Suisse International,
Credit Suisse Investments (UK), Credit Suisse Investment Holdings (UK),
Credit Suisse Securities (Europe) Ltd.). The (financial/other) instruments
pursuant to section 25a WpHG are described as follows: Right to recall from
securities lending, maturity at any time.

2) On 2 July 2012, Credit Suisse AG exceeded the threshold of 5% of the
voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt
a. d. Saale, Germany. On that date, Credit Suisse AG held 5.81% of the
voting rights in RHÖN-KLINIKUM AG (equals 8,025,638 voting rights). From
these voting rights a proportion of 3.83% (equals 5.294.944 voting rights)
is based on voting rights pursuant to sections 21, 22 WpHG and a proportion
of 1.98% (equals 2,730,694 voting rights) is based on (financial / other)
instruments pursuant to section 25 WpHG. From the voting rights based on
instruments pursuant to section 25 WpHG a proportion of 1.98% (equals
2,730,694 voting rights) is held indirectly (chain of controlled
undertakings: Credit Suisse International, Credit Suisse Investments (UK),
Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe)
Ltd.). The (financial/other) instruments pursuant to section 25a WpHG are
described as follows: Right to recall from securities lending, maturity at
any time.

Bad Neustadt a.d. Saale, 9 July 2012

The Board of Management

___________________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



09.07.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

Die DF-Anleihe 7,875%

Mit der DF Forfait AG vom wachsenden Welthandel profitieren

- Zeichnungsfrist: 21.05. bis 24.05.2013
- Laufzeit: 7 Jahre
- Kupon: 7,875% p.a.
- Volumen: bis zu 30 Mio. Euro
- ISIN: DE000A1R1CC4

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

HELMA Eigenheimbau AG: Kaufen

Die HELMA Eigenheimbau AG präsentierte für das Geschäftsjahr 2012 Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen fairen Wert je Aktie von 22,75 € ermittelt. Ausgehend vom erwarteten 2013er-EPS von 1,64 € entspricht dies einem KGV von 8,4. Das Kurspotenzial beläuft sich auf nahezu 65%.

News im Fokus

Fresenius Medical Care AG & Co. KGaA: Bekanntmachung nach Art. 4 Abs. 2 der Verordnung (EG) Nr. 2273/2003

17. Mai 2013, 17:35

Aktueller Webcast

Allianz SE

Analysts' conference call on 1Q 2013

15. Mai 2013

Aktuelle Research-Studie

Original-Research: Plan Optik AG (von GBC AG): Kaufen Plan Optik AG

17. Mai 2013